Tubular heart valves from decellularized engineered tissue

Zeeshan H. Syedain, Lee A. Meier, Jay M. Reimer, Robert T. Tranquillo

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A novel tissue-engineered heart valve (TEHV) was fabricated from a decellularized tissue tube mounted on a frame with three struts, which upon back-pressure cause the tube to collapse into three coapting "leaflets." The tissue was completely biological, fabricated from ovine fibroblasts dispersed within a fibrin gel, compacted into a circumferentially aligned tube on a mandrel, and matured using a bioreactor system that applied cyclic distension. Following decellularization, the resulting tissue possessed tensile mechanical properties, mechanical anisotropy, and collagen content that were comparable to native pulmonary valve leaflets. When mounted on a custom frame and tested within a pulse duplicator system, the tubular TEHV displayed excellent function under both aortic and pulmonary conditions, with minimal regurgitant fractions and transvalvular pressure gradients at peak systole, as well as well as effective orifice areas exceeding those of current commercially available valve replacements. Short-term fatigue testing of one million cycles with pulmonary pressure gradients was conducted without significant change in mechanical properties and no observable macroscopic tissue deterioration. This study presents an attractive potential alternative to current tissue valve replacements due to its avoidance of chemical fixation and utilization of a tissue conducive to recellularization by host cell infiltration.

Original languageEnglish (US)
Pages (from-to)2645-2654
Number of pages10
JournalAnnals of Biomedical Engineering
Volume41
Issue number12
DOIs
StatePublished - Jul 30 2013

Fingerprint

Tissue
Pressure gradient
Mechanical properties
Fatigue testing
Struts
Fibroblasts
Orifices
Bioreactors
Infiltration
Collagen
Deterioration
Anisotropy
Gels

Keywords

  • Decellularization
  • Heart valve
  • Pulse duplicator
  • Tissue engineering

Cite this

Tubular heart valves from decellularized engineered tissue. / Syedain, Zeeshan H.; Meier, Lee A.; Reimer, Jay M.; Tranquillo, Robert T.

In: Annals of Biomedical Engineering, Vol. 41, No. 12, 30.07.2013, p. 2645-2654.

Research output: Contribution to journalArticle

@article{add85f2b97bd4c379ead3ce6a946a4e5,
title = "Tubular heart valves from decellularized engineered tissue",
abstract = "A novel tissue-engineered heart valve (TEHV) was fabricated from a decellularized tissue tube mounted on a frame with three struts, which upon back-pressure cause the tube to collapse into three coapting {"}leaflets.{"} The tissue was completely biological, fabricated from ovine fibroblasts dispersed within a fibrin gel, compacted into a circumferentially aligned tube on a mandrel, and matured using a bioreactor system that applied cyclic distension. Following decellularization, the resulting tissue possessed tensile mechanical properties, mechanical anisotropy, and collagen content that were comparable to native pulmonary valve leaflets. When mounted on a custom frame and tested within a pulse duplicator system, the tubular TEHV displayed excellent function under both aortic and pulmonary conditions, with minimal regurgitant fractions and transvalvular pressure gradients at peak systole, as well as well as effective orifice areas exceeding those of current commercially available valve replacements. Short-term fatigue testing of one million cycles with pulmonary pressure gradients was conducted without significant change in mechanical properties and no observable macroscopic tissue deterioration. This study presents an attractive potential alternative to current tissue valve replacements due to its avoidance of chemical fixation and utilization of a tissue conducive to recellularization by host cell infiltration.",
keywords = "Decellularization, Heart valve, Pulse duplicator, Tissue engineering",
author = "Syedain, {Zeeshan H.} and Meier, {Lee A.} and Reimer, {Jay M.} and Tranquillo, {Robert T.}",
year = "2013",
month = "7",
day = "30",
doi = "10.1007/s10439-013-0872-9",
language = "English (US)",
volume = "41",
pages = "2645--2654",
journal = "Annals of Biomedical Engineering",
issn = "0090-6964",
publisher = "Springer Netherlands",
number = "12",

}

TY - JOUR

T1 - Tubular heart valves from decellularized engineered tissue

AU - Syedain, Zeeshan H.

AU - Meier, Lee A.

AU - Reimer, Jay M.

AU - Tranquillo, Robert T.

PY - 2013/7/30

Y1 - 2013/7/30

N2 - A novel tissue-engineered heart valve (TEHV) was fabricated from a decellularized tissue tube mounted on a frame with three struts, which upon back-pressure cause the tube to collapse into three coapting "leaflets." The tissue was completely biological, fabricated from ovine fibroblasts dispersed within a fibrin gel, compacted into a circumferentially aligned tube on a mandrel, and matured using a bioreactor system that applied cyclic distension. Following decellularization, the resulting tissue possessed tensile mechanical properties, mechanical anisotropy, and collagen content that were comparable to native pulmonary valve leaflets. When mounted on a custom frame and tested within a pulse duplicator system, the tubular TEHV displayed excellent function under both aortic and pulmonary conditions, with minimal regurgitant fractions and transvalvular pressure gradients at peak systole, as well as well as effective orifice areas exceeding those of current commercially available valve replacements. Short-term fatigue testing of one million cycles with pulmonary pressure gradients was conducted without significant change in mechanical properties and no observable macroscopic tissue deterioration. This study presents an attractive potential alternative to current tissue valve replacements due to its avoidance of chemical fixation and utilization of a tissue conducive to recellularization by host cell infiltration.

AB - A novel tissue-engineered heart valve (TEHV) was fabricated from a decellularized tissue tube mounted on a frame with three struts, which upon back-pressure cause the tube to collapse into three coapting "leaflets." The tissue was completely biological, fabricated from ovine fibroblasts dispersed within a fibrin gel, compacted into a circumferentially aligned tube on a mandrel, and matured using a bioreactor system that applied cyclic distension. Following decellularization, the resulting tissue possessed tensile mechanical properties, mechanical anisotropy, and collagen content that were comparable to native pulmonary valve leaflets. When mounted on a custom frame and tested within a pulse duplicator system, the tubular TEHV displayed excellent function under both aortic and pulmonary conditions, with minimal regurgitant fractions and transvalvular pressure gradients at peak systole, as well as well as effective orifice areas exceeding those of current commercially available valve replacements. Short-term fatigue testing of one million cycles with pulmonary pressure gradients was conducted without significant change in mechanical properties and no observable macroscopic tissue deterioration. This study presents an attractive potential alternative to current tissue valve replacements due to its avoidance of chemical fixation and utilization of a tissue conducive to recellularization by host cell infiltration.

KW - Decellularization

KW - Heart valve

KW - Pulse duplicator

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84896723077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896723077&partnerID=8YFLogxK

U2 - 10.1007/s10439-013-0872-9

DO - 10.1007/s10439-013-0872-9

M3 - Article

VL - 41

SP - 2645

EP - 2654

JO - Annals of Biomedical Engineering

JF - Annals of Biomedical Engineering

SN - 0090-6964

IS - 12

ER -